Nobivac Feline 1-HCPCH + FeLV Vaccine for Cats, 25 Doses

Core + FeLV Protection for At-Risk Cats

Product Description

Nobivac Feline 1-HCPCh + FeLV Vaccine for Cats is a combination vaccine for healthy cats 9 weeks of age or older. It is shown to be effective against feline rhinotracheitis, calicivirus, panleukopenia, Chlamydia psittaci, and feline leukemia virus (FeLV). The FeLV component provides at least a two-year duration of immunity. Two doses are required for primary immunization.

Benefits

• Five-Disease Coverage: Protects against FVR, FCV, FPV, Chlamydia psittaci, and FeLV.
• FeLV DOI Support: FeLV component provides at least a two-year duration of immunity.
• Broad Protection Plan: Supports cats with higher exposure in multi-cat settings.
• Primary Series Clarity: Requires two initial doses for primary immunization.
• Clinic-Ready Format: Supplied as a 25-dose (1 mL per dose) presentation.

Ingredients

Active Ingredients: Modified live viral components for rhinotracheitis, calicivirus, and panleukopenia; Chlamydia (modified/live component); and an inactivated (killed) FeLV component.
Preservatives: Amphotericin B, gentamicin.

How to Use

Dosage & Administration Instructions

• Warm and Shake: Warm the FeLV vial to room temperature; shake well.
• Reconstitute Properly: Transfer FeLV vial contents into 1-HCPCh vial aseptically.
• Mix Gently: Mix until dissolved; use entire contents immediately.
• Initial Dose: Inject 1 mL SQ or IM at 9 weeks or older.
• Second Dose: Inject 1 mL SQ or IM 3-4 weeks later.

Additional Information

Precautions

• Refrigeration Required: Store at 2°-7/8°C and do not freeze.
• Sterile Equipment: Use new, non-chemically sterilized needles and syringes.
• No Extra Mixing: Do not mix with other vaccines or products.
• Pregnancy Warning: Do not vaccinate pregnant cats.
• Reaction Readiness: Hypersensitivity reactions may occur; monitor and treat as needed.

Shipping & Returns

We offer ground, express, priority, and international delivery; see our shipping policy for details.

For return instructions or product concerns, please refer to our detailed refund policy.

NOTICE: This item requires Express Shipping due to its perishable nature. Express orders are shipped Monday - Wednesday. Cannot be shipped to a P.O. box. The product can only be shipped to the continental US. Please note that a signature will be required upon delivery to confirm receipt of the order.

Frequently Asked Questions

Q1: What does Nobivac Feline 1-HCPCh + FeLV Vaccine protect against?

Ans: Nobivac Feline 1-HCPCh + FeLV Vaccine is shown to be effective against feline rhinotracheitis, calicivirus, panleukopenia, Chlamydia psittaci, and feline leukemia virus (FeLV). It is intended for healthy cats 9 weeks of age or older.

Q2: What is the starting age for vaccination?

Ans: The labeled starting age is 9 weeks or older for healthy cats and kittens. Starting at the recommended age supports timely protection planning, especially for cats that may enter shelters, rescues, boarding, or multi-cat homes.

Q3: What is the primary vaccination schedule?

Ans: Two doses are required for primary immunization. Give the first 1 mL dose at 9 weeks of age or older, then administer a second 1 mL dose 3-4 weeks after the initial vaccination.

Q4: What is the dose size and route of administration?

Ans: Each dose is 1 mL. The vaccine is administered by injection, either subcutaneously (SQ) or intramuscularly (IM). Trained veterinary professionals should follow proper aseptic techniques and correct reconstitution steps.

Q5: How do you reconstitute the vaccine before injection?

Ans: Warm the FeLV vial to room temperature and shake well. Transfer the FeLV vial contents into the 1-HCPCh vial aseptically, then mix gently until dissolved. Use the entire reconstituted contents immediately after preparation.

Q6: How long does FeLV immunity last with this vaccine?

Ans: The FeLV component provides a duration of immunity of at least 2 years. Duration of immunity for rhinotracheitis, calicivirus, panleukopenia, and Chlamydia psittaci has not been established in the label information.

Q7: What preservatives are included in the formulation?

Ans: The label warnings list gentamicin and amphotericin B as preservatives. These preservatives are part of the product formulation, so ingredient review can be helpful when evaluating sensitivities and handling requirements in a clinical setting.

Q8: Should cats be tested for FeLV before vaccination?

Ans: Yes. Label guidance recommends diagnostic testing for FeLV antigen before vaccination, because prior exposure or latent infection may affect whether vaccination alters the course of disease. Testing supports better risk assessment and vaccination planning.

Q9: What safety precautions should clinics follow when using this vaccine?

Ans: Store refrigerated and do not freeze. Use new, non-chemically sterilized needles and syringes, do not mix with other vaccines, and inactivate unused contents before disposal. Do not vaccinate pregnant cats and monitor for hypersensitivity reactions.